7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium

Research output: Contribution to journalJournal articleResearchpeer-review

Roger L Milne, Justo Lorenzo-Bermejo, Barbara Burwinkel, Núria Malats, Jose Ignacio Arias, M Pilar Zamora, Javier Benítez, Manjeet K Humphreys, Montserrat García-Closas, Stephen J Chanock, Jolanta Lissowska, Mark E Sherman, Arto Mannermaa, Vesa Kataja, Veli-Matti Kosma, Heli Nevanlinna, Tuomas Heikkinen, Kristiina Aittomäki, Carl Blomqvist, Hoda Anton-Culver & 31 others Argyrios Ziogas, Peter Devilee, Christie J van Asperen, Rob A E M Tollenaar, Caroline Seynaeve, Per Hall, Kamila Czene, Jianjun Liu, Astrid K Irwanto, Daehee Kang, Keun-Young Yoo, Dong-Young Noh, Fergus J Couch, Janet E Olson, Xianshu Wang, Zachary Fredericksen, Børge G Nordestgaard, Stig E Bojesen, Henrik Flyger, Sara Margolin, Annika Lindblom, Peter A Fasching, Ruediger Schulz-Wendtland, Arif B Ekici, Matthias W Beckmann, Shan Wang-Gohrke, Chen-Yang Shen, Jyh-Cherng Yu, Huan-Ming Hsu, Pei-Ei Wu, AOCS Group

Using the Breast Cancer Association Consortium, the authors previously reported that the single nucleotide polymorphism 7q21-rs6964587 (AKAP9-M463I) is associated with breast cancer risk. The authors have now assessed this association more comprehensively using 16 independent case-control studies.
Original languageEnglish
JournalJournal of Medical Genetics
Volume48
Issue number10
Pages (from-to)698-702
Number of pages5
ISSN0022-2593
DOIs
Publication statusPublished - 2011

ID: 40184190